Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiya Yu

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Immunological Reviews|January 5, 2011
Therapeutic cancer vaccines: are we there yet?Christopher A Klebanoff, Nicolas Acquavella, Zhiya Yu, et al.
Cancer Research|January 21, 2006
The in vivo expansion rate of properly stimulated transferred CD8+ T cells exceeds that of an aggressively growing mouse tumorLeroy N Hwang, Zhiya Yu, Douglas C Palmer, et al.
Blood|July 16, 2010
Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cellsJames N Kochenderfer, Zhiya Yu, Dorina Frasheri, et al.
Thyroid : Official Journal of the American Thyroid Association|November 23, 2013
An in vivo mouse model of metastatic human thyroid cancerLisa Zhang, Kelli Gaskins, Zhiya Yu, et al.
JCI Insight|May 17, 2019
An effective mouse model for adoptive cancer immunotherapy targeting neoantigensKen-Ichi Hanada, Zhiya Yu, Gabrielle R Chappell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine designOleg Y Borbulevych, Tiffany K Baxter, Zhiya Yu, et al.
Cancer Research|May 2, 2013
Simultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in miceDhanalakshmi Chinnasamy, Eric Tran, Zhiya Yu, et al.
Cancer Research|July 16, 2010
Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancerRajeev K Shrimali, Zhiya Yu, Marc R Theoret, et al.
Cancer Immunology Research|December 25, 2015
Identification of T-cell Receptors Targeting KRAS-Mutated Human TumorsQiong J Wang, Zhiya Yu, Kayla Griffith, et al.
Blood|June 30, 2009
Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccinationChristopher A Klebanoff, Zhiya Yu, Leroy N Hwang, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Immunological Reviews|January 5, 2011
Therapeutic cancer vaccines: are we there yet?Christopher A Klebanoff, Nicolas Acquavella, Zhiya Yu, et al.
Cancer Research|January 21, 2006
The in vivo expansion rate of properly stimulated transferred CD8+ T cells exceeds that of an aggressively growing mouse tumorLeroy N Hwang, Zhiya Yu, Douglas C Palmer, et al.
Blood|July 16, 2010
Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cellsJames N Kochenderfer, Zhiya Yu, Dorina Frasheri, et al.
Thyroid : Official Journal of the American Thyroid Association|November 23, 2013
An in vivo mouse model of metastatic human thyroid cancerLisa Zhang, Kelli Gaskins, Zhiya Yu, et al.
JCI Insight|May 17, 2019
An effective mouse model for adoptive cancer immunotherapy targeting neoantigensKen-Ichi Hanada, Zhiya Yu, Gabrielle R Chappell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine designOleg Y Borbulevych, Tiffany K Baxter, Zhiya Yu, et al.
Cancer Research|May 2, 2013
Simultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in miceDhanalakshmi Chinnasamy, Eric Tran, Zhiya Yu, et al.
Cancer Research|July 16, 2010
Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancerRajeev K Shrimali, Zhiya Yu, Marc R Theoret, et al.
Cancer Immunology Research|December 25, 2015
Identification of T-cell Receptors Targeting KRAS-Mutated Human TumorsQiong J Wang, Zhiya Yu, Kayla Griffith, et al.
Blood|June 30, 2009
Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccinationChristopher A Klebanoff, Zhiya Yu, Leroy N Hwang, et al.
Pageof 9